PRODUCTS & INNOVATION
Ahead of expectations through the first half of the year, company raises guidance.
Jul 20 2017
Abbott had another strong quarter in Q2 2017. We committed to strong double-digit underlying growth at the beginning of the year, and we continue to deliver solid results on both on the top and bottom line.
Half-way through the year Abbott is seeing several successes as we continue to shape our company to align to current and future healthcare needs around the world.
Full financials are detailed in this news release. Among the highlights in the quarter:
Abbott's Chairman and CEO Miles D. White shares his views on second-quarter performance:
Learn more about Abbott's second-quarter 2017 results:
Click here to download a summary of Abbott's earnings highlights.
For more information on Abbott's earnings results, see the news release.
At the Forefront of Mending the Brain
Abbott Reports Strong Growth in First Quarter
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.